|
Imdrf investigation findings code c20 (no findings available) has been selected, as code c24 is not available in the database to capture (malfunction observed without conclusive finding).Imdrf cause conclusions code d16 (conclusion not yet available) has been selected, as code d1501 is not available in database to capture (cause linked to device but unable to trace more specifically).Initial 1 of 2.E1: (b)(6).Imdrf cause investigation code: code c24 is not available in database to capture malfunction observed without conclusive finding.Imdrf cause conclusions code: code d1501 is not available in database to capture cause linked to device but unable to trace more specifically.Additional information - this medical device report (mdr)is being submitted to include the below:
h6: investigation results under type of investigation, investigation findings, investigation conclusions.H11: investigation summary.Complaint investigation results:
investigation of complaint record database (b)(4) was performed based on the event description, lot number, and the assigned malfunction code adhesive patch completely detaches during use- detachment / significant wetness.Upon review of the electronic quality management system (eqms) and related records, a capa related to adhesive issues was identified.Corrective and preventive action (capa)s-2010953 was opened for adhesive related complaints.An analysis of adhesive complaints from january 2024 until october 2025 was performed as part of the investigation.Root cause of problem:
conclusion of the investigation showed the ewis instructions for use (ifu) does not provide adequate information relating to preparation of the skin when in hot and humid environments and the design verification data is lacking peel-test data along with validated test methods to quantify adhesion performance.Corrective action as a result of the investigation:
corrective actions taken to update the ewis ifu and complete test method validation and verification testing.Is complaint confirmed.Based on the information provided in the complaint and capa-2010953 investigation conclusion, the complaint will be closed as complaint confirmed by accurate description of malfunction and/or harm.Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number
reporting site: 8021545
manufacturing site: 8021545.
|